Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jonathan Ashley Jefferson"'
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis
Autor:
John F. O’Toole, Katherine R. Tuttle, Kevin V. Lemley, Matthew G. Sampson, Marie C. Hogan, Jarcy Zee, Michelle T McNulty, Sharon G. Adler, Vimal K. Derebail, Chia-shi Wang, Raed Bou Matar, Elizabeth J. Brown, Katherine MacRae Dell, Fernando C. Fervenza, Keisha L. Gibson, Gerald B. Appel, Cynthia C. Nast, Ambarish M. Athavale, Pamela Singer, Jonathan Ashley Jefferson, Richard A. Lafayette, Jeffrey B. Kopp, Larry A. Greenbaum, Kevin E.C. Meyers, Laura Barisoni, Alessia Fornoni, Jiten Patel, Kamalanathan K. Sambandam, Crystal A. Gadegbeku, Meredith A. Atkinson, Serena M. Bagnasco, Matthias Kretzler, Jonathan J. Hogan, Heather N. Reich, Suzanne Vento, Howard Trachtman, Jen Jar Lin, Jeffrey B. Hodgin, Lawrence B. Holzman, Tarak Srivastava, Sangeeta Hingorani, Frederick J. Kaskel, Michelle Hladunewich, Olga Zhdanova, Christine B. Sethna, Dhruti P. Chen, Debbie S. Gipson, John C. Lieske
Publikováno v:
Pediatr Nephrol
Background: The G1 and G2 alleles of apolipoprotein L1 (APOL1) are common in the Black population and associated with increased risk of focal segmental glomerulosclerosis (FSGS). The molecular mechanisms linking APOL1 risk variants with FSGS are not
Autor:
Nisha Bansal, Nayan Arora, David Mariuma, Jonathan Ashley Jefferson, Kevin O’Brien, Stuart Shankland
Publikováno v:
Kidney360
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab156cf610e60761bdbe7153fcf8ba73
https://europepmc.org/articles/PMC9136897/
https://europepmc.org/articles/PMC9136897/
Publikováno v:
Current Rheumatology Reviews. 15:224-228
Background: It is unclear whether patients with Anti-Glomerular Basement Membrane (GBM) disease and Anti-Neutrophil Cytoplasmic Antibodies (ANCA), so called “Double-Positive” (DP), have a different clinical presentation and outcome compared to pa
Autor:
Ellen T. McCarthy, Brad H. Rovin, Sanjeev Sethi, James F. Simon, Patrick E. Gipson, Sean J. Barbour, Paul Brenchley, Lee A. Hebert, John R. Sedor, Fernando C. Fervenza, Jonathan Ashley Jefferson, Nelson Leung, Tingting Li, Michelle Hladunewich, Daniel C Cattran, Lada Beara-Lasic, Pietro A. Canetta, Heather Beanlands, Carmen Avila-Casado, Amy N. Sussman, Stephen B. Erickson, Bruno R. da Costa, Dana V. Rizk, Jay Radhakrishnan, Heather N. Reich, Richard A. Lafayette, Dolly F. Green, Gerald B. Appel, David Philibert, Luis A. Juncos, Nabeel Aslam, Samir V. Parikh, Dominic K. Lee, Lesley F. Thomas, Samuel S. Blumenthal, Debbie S. Gipson, John C. Lieske, Peter Jüni
Publikováno v:
MENTOR Investigators 2019, ' Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy ', The New England Journal of Medicine, vol. 381, no. 1, pp. 36-46 . https://doi.org/10.1056/NEJMoa1814427
BACKGROUND: B-cell anomalies play a role in the pathogenesis of membranous nephropathy. B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for inducing and maintaining a complete or partial remission of protei
Autor:
Daniel C. Cattran, Ambarish M. Athavale, Noelle E. Carlozzi, Kevin V. Lemley, Elizabeth J. Brown, David T. Selewski, Meredith A. Atkinson, Christine B. Sethna, Pamela Singer, Katherine R. Tuttle, Fernando C. Fervenza, Shannon Murphy, Crystal A. Gadegbeku, Debbie S. Gipson, John C. Lieske, Frederick J. Kaskel, Jonathan Ashley Jefferson, Larry A. Greenbaum, Sangeeta Hingorani, Jen Jar Lin, Alessia Fornoni, Sharon G. Adler, Vimal K. Derebail, Patrick H. Nachman, Lawrence B. Holzman, Matthias Kretzler, Jeffrey B. Kopp, Keisha L. Gibson, Gerald B. Appel, Kimberly J. Reidy, Michelle A. Hladunewich, Tarak Srivastava, Kamalanathan K. Sambandam, Chia-shi Wang, Emily Herreshoff, John R. Sedor, Richard A. Lafayette, Marie C. Hogan, Kevin E.C. Meyers, Frank Modersitzki, Heather N. Reich, Laura Barisoni, Anne Waldo, Howard Trachtman, Katherine MacRae Dell, Jonathan P. Troost
Publikováno v:
Clinical Kidney Journal
Background Understanding the relationship between clinical and patient-reported outcomes (PROs) will help support clinical care and future clinical trial design of novel therapies for focal segmental glomerulosclerosis (FSGS). Methods FSGS patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284a32e375387c1eff25462cc5602ca2
Autor:
Rajiv Agarwal, Talal Alfaadhel, Martin J. Andersen, John Robert Asplin, Rupali S. Avasare, George L. Bakris, Amar D. Bansal, Pravir V. Baxi, Michael Berkoben, Scott D. Bieber, Florian Buchkremer, Anna Marie Burgner, James Brian Byrd, Daniel Cattran, Devasmita Choudhury, Rolando Claure-Del Granado, Bradley M. Denker, Vimal K. Derebail, Robert J. Desnick, Luca di Lullo, John V. Duronville, Garabed Eknoyan, Mina El Kateb, William J. Elliott, Jennifer L. Ennis, Fernando C. Fervenza, Robert A. Figlin, Zita Galvin, Pranav S. Garimella, Debbie S. Gipson, Patrick E. Gipson, David S. Goldfarb, Arthur Greenberg, Hermann Haller, Swapnil Hiremath, Edward J. Horwitz, Susan Hou, Lesley A. Inker, Maria V. Irazabal, Ashley Bruce Irish, Kenar D. Jhaveri, Jonathan Ashley Jefferson, Kamyar Kalantar-Zadeh, Elaine S. Kamil, Jon-Emile S. Kenny, Charbel C. Khoury, Jatinder Kohli, Eugene C. Kovalik, Csaba P. Kovesdy, Warren Kupin, Ruediger W. Lehrich, Edgar V. Lerma, Moshe Levi, Joseph L. Lockridge, Jennifer Lopez, Etienne Macedo, Rajnish Mehrotra, Ravindra L. Mehta, Patrick H. Nachman, Carol Nadai, Lavinia Aura Negrea, Lindsay E. Nicolle, Keith C. Norris, Alexander Novakovic, Ali J. Olyaei, Sumanta Kumar Pal, Paul M. Palevsky, Ami M. Patel, Vikram Patney, Mark A. Perazella, Phuong-Chi T. Pham, Phuong-Thu T. Pham, Joseph B. Pryor, C. Venkata S. Ram, Mahboob Rahman, MD, Nathaniel Reisinger, Michael V. Rocco, Claudio Ronco, Mark E. Rosenberg, Mitchell H. Rosner, Michael R. Rudnick, Ernesto Sabath, Mark J. Sarnak, Jane O. Schell, N. Winn Seay, John R. Sedor, Akash Nair Sethi, Anuja Shah, Lori Shah, Benjamin A. Sherer, Harpreet Singh, Rajalingam Sinniah, James A. Sloand, Matthew A. Sparks, Stuart M. Sprague, Susan Patricia Steigerwalt, Hillel Sternlicht, Marshall L. Stoller, Beje Thomas, Hakan R. Toka, Joel M. Topf, Vicente E. Torres, Howard Trachtman, Carol Traynor, Bryan M. Tucker, Beth A. Vogt, Rimda Wanchoo, Matthew R. Weir, Adam Whaley-Connell, William L. Whittier, Jay B. Wish, Florence Wong, David C. Wymer, David T.G. Wymer, Ladan Zand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79fe2f8a060c7f93e83fad6515e76915
https://doi.org/10.1016/b978-0-323-47871-7.00004-6
https://doi.org/10.1016/b978-0-323-47871-7.00004-6
Autor:
Behzad Najafian, Nicolae Leca, Aleksandra Kukla, David H. Maurer, Jonathan Ashley Jefferson, Karen Nelson, Kimberly A. Muczynski, N. Kieran, Christopher D. Blosser, Morayma Reyes, Wayne L. Chandler, Cindy M. Tower
Publikováno v:
Transplantation. 101(9)
Antibody-mediated rejection (AMR) is a major cause of kidney allograft loss. Currently, AMR diagnosis relies on biopsy which is an invasive procedure. A noninvasive biomarker of acute AMR could lead to early diagnosis and treatment of this condition
Publikováno v:
Kidney International. 74:22-36
Proteinuria is the hallmark of diabetic kidney disease (DKD) and is an independent risk factor for both renal disease progression, and cardiovascular disease. Although the characteristic pathological changes in DKD include thickening of the glomerula
Autor:
Michael Mauer, Brent Fall, C. Ronald Scott, Behzad Najafian, Eric Wallace, Jeffrey W. Pippin, David G. Warnock, Jonathan Ashley Jefferson, Stuart J. Shankland
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0168346 (2016)
PLoS ONE
PLoS ONE
Chronic kidney disease is a major complication of Fabry disease. Podocytes accumulate globotriaosylceramide inclusions more than other kidney cell types in Fabry patients. Podocyte injury occurs early in age, and is progressive. Since injured podocyt